Skip to content
Search or ask
News · BusinessBrand announcementPR-supplied

Medicilon gives Revolution Medicines an award for customer partnership excellence

The honour follows a visit by two Revolution Medicines scientists to Medicilon's Nanhui R&D centre, according to a press release.

By idly desk · from 1 report · · 1 min read
AI-assisted
idly reads every outlet that covered this story, writes one summary with AI help, and checks it against the originals before it goes live. The sources are listed below so you can read them yourself. How idly works

The gist

Story
  • Medicilon presented Revolution Medicines with a 'Customer Partnership Excellence' award, per a PR Newswire release…
  • Two Revolution Medicines scientists visited Medicilon's Nanhui research and development centre.
  • The details come from the companies' own announcement, distributed in several languages.

What's new

Medicilon has given an award for customer partnership excellence to Revolution Medicines, Inc., according to a press release distributed by PR Newswire from Boston on 30 October 2026. The release says Dr. Yang Liu, head of medicinal chemistry at Revolution Medicines, and Dr. Kristof Pota, a principal scientist, visited Medicilon's research and development centre in Nanhui. The visiting scientists were welcomed by Dr. Maosheng Duan, who leads Medicilon's drug discovery divisions.

Why it matters

The announcement describes a collaboration between a contract research firm and a drug developer. It offers a view of how the two companies work together, though it does not describe the work itself in detail.

What we don't know yet

The release does not say what the partnership involves, what the award criteria were, or what projects the companies are pursuing. The details come from the companies' own announcement, not from an independent source.

Worth your time?

One tap helps idly bring you more of what matters.

Read the originals

3 outlets

Advertisement